MedicalBen
    Facebook Twitter Instagram
    MedicalBen
    • Home
    • Internal Medicine
      • Respiratory Medicine
      • Gastroenterology
      • Cardiology
      • Neurology
    • Surgery
      • Anasthesiology
      • Cardiothoracic Surgery
    Facebook Twitter Instagram
    MedicalBen
    Cardiology

    Infective Endocarditis: Causes, Diagnosis, and Management

    Dr BenBy Dr BenMarch 17, 2025No Comments4 Mins Read
    Infective Endocarditis: Causes, Diagnosis, and Management

    Infective Endocarditis (IE) is a life-threatening infection of the heart’s endocardium, most commonly affecting heart valves. It can lead to valvular destruction, heart failure, embolic events, and multi-organ complications. Early recognition and treatment are crucial to reduce morbidity and mortality.


    2. Classification of Infective Endocarditis

    Type Description
    Acute IE Rapid onset, highly virulent organisms (e.g., Staphylococcus aureus), aggressive progression
    Subacute IE Indolent course, less virulent organisms (e.g., Streptococcus viridans), occurs on pre-existing valve disease
    Native Valve Endocarditis (NVE) Infection on natural heart valves
    Prosthetic Valve Endocarditis (PVE) Infection on prosthetic heart valves (early: <1 year post-surgery, late: >1 year post-surgery)
    Intravenous Drug Use (IVDU) Endocarditis Commonly affects the tricuspid valve, caused by Staphylococcus aureus

    3. Risk Factors

    Category Risk Factors
    Structural Heart Disease Rheumatic heart disease, bicuspid aortic valve, mitral valve prolapse
    Prosthetic Material Prosthetic valves, indwelling cardiac devices (pacemakers, ICDs)
    IV Drug Use Staphylococcus aureus is the most common causative organism
    Immunosuppression HIV, chemotherapy, long-term corticosteroids
    Recent Procedures Dental procedures, hemodialysis, intravascular catheters

    4. Pathophysiology

    1. Endothelial Injury → Turbulent blood flow (e.g., valvular disease) damages the endocardium.
    2. Platelet & Fibrin Deposition → Forms a non-bacterial thrombotic endocarditis (NBTE).
    3. Bacteremia → Organisms adhere to the thrombus, leading to vegetation formation.
    4. Embolization & Systemic Effects → Fragments of vegetation break off, causing stroke, infarcts, or septic emboli.

    5. Clinical Features

    (A) General Symptoms

    Symptoms Findings
    Fever & Malaise Most common symptom (present in ~90%)
    Night Sweats & Weight Loss Seen in subacute IE
    New or Changing Murmur Indicates valvular involvement

    (B) Classic Signs of Infective Endocarditis

    Sign Description
    Osler’s Nodes Painful, red nodules on fingertips/toes (immune complex deposition)
    Janeway Lesions Non-tender macules on palms/soles (microemboli)
    Splinter Hemorrhages Linear hemorrhages under fingernails
    Roth Spots Retinal hemorrhages with pale centers
    Clubbing Chronic IE cases
    Splenomegaly More common in subacute IE

    (C) Embolic & Systemic Manifestations

    Complication Affected Organ Presentation
    Stroke Brain Focal neurological deficits
    Renal Infarct Kidneys Hematuria, flank pain
    Septic Pulmonary Emboli Lungs (IVDU-associated IE) Respiratory symptoms, cavitary lesions on CXR
    Mycotic Aneurysm Blood vessels Risk of rupture and hemorrhage
    See also  Myocardial Infarction (MI): Pathophysiology, Diagnosis, and Management

    6. Diagnosis of Infective Endocarditis

    (A) Duke Criteria for IE Diagnosis

    IE is diagnosed using the Modified Duke Criteria, which include major and minor criteria.

    Major Criteria

    1. Positive Blood Cultures
      • Staphylococcus aureus, Streptococcus viridans, Enterococcus (typical IE pathogens)
      • Persistent bacteremia (≥2 positive blood cultures >12 hours apart)
    2. Endocardial Involvement (Echocardiography)
      • Vegetation, abscess, or new dehiscence of prosthetic valve on transesophageal echocardiography (TEE)

    Minor Criteria

    1. Predisposing Risk Factor (e.g., prosthetic valve, IVDU, heart disease)
    2. Fever >38°C
    3. Vascular Phenomena (e.g., Janeway lesions, embolic events)
    4. Immunologic Phenomena (e.g., Osler’s nodes, Roth spots)
    5. Microbiological Evidence (e.g., positive culture not meeting major criteria)

    Definitive IE = 2 Major or 1 Major + 3 Minor or 5 Minor
    Possible IE = 1 Major + 1 Minor or 3 Minor

    (B) Laboratory & Imaging Workup

    Investigation Findings
    Blood Cultures (3 sets before antibiotics) Bacteremia
    Full Blood Count (FBC) Leukocytosis, anemia
    Inflammatory Markers ↑ ESR, CRP
    Transesophageal Echocardiogram (TEE) Gold standard for detecting vegetations
    ECG May show conduction abnormalities (suggests abscess)
    CT/MRI To assess embolic complications

    7. Management of Infective Endocarditis

    (A) Empirical Antibiotic Therapy (Before Culture Results)

    Suspected Organism First-Line Empirical Therapy
    Native Valve (NVE) IV Vancomycin + IV Gentamicin
    Prosthetic Valve (PVE) IV Vancomycin + IV Gentamicin + IV Rifampicin
    IV Drug User (Tricuspid IE) IV Vancomycin

    (B) Targeted Antibiotic Therapy (After Culture Results)

    Causative Organism Antibiotic Regimen Duration
    Staphylococcus aureus IV Flucloxacillin (MSSA) / IV Vancomycin (MRSA) 4–6 weeks
    Streptococcus viridans IV Benzylpenicillin ± Gentamicin 4 weeks
    Enterococcus spp. IV Ampicillin + Gentamicin 4–6 weeks
    HACEK Group IV Ceftriaxone 4 weeks

    🚨 Prosthetic Valve IE requires ≥6 weeks of therapy
    🚨 IV to oral switch is NOT recommended

    (C) Indications for Surgery

    Indication Rationale
    Severe Valve Dysfunction Refractory heart failure
    Large Vegetations (>10 mm) High embolic risk
    Persistent Infection Positive blood cultures despite antibiotics
    Prosthetic Valve Endocarditis Higher risk of complications
    Abscess Formation Conduction abnormalities (AV block on ECG)

    8. Prevention of Infective Endocarditis

    (A) Who Needs Prophylaxis?

    High-Risk Group Examples
    Prosthetic Valves Mechanical or bioprosthetic valves
    Previous Infective Endocarditis History of IE
    Congenital Heart Disease Unrepaired cyanotic defects, repaired defects with prosthetics
    See also  Atrial Fibrillation (AF): Causes, Diagnosis, and Management

    (B) Antibiotic Prophylaxis for High-Risk Procedures

    Procedure Prophylactic Antibiotic
    Dental (gingival manipulation) Amoxicillin 2g PO (or Clindamycin 600mg if allergic)
    Respiratory (bronchoscopy with biopsy) Amoxicillin 2g IV
    GI/GU Procedures Not routinely recommended

    9. Key Takeaways

    ✅ Fever + new murmur = Suspect IE!
    ✅ Duke Criteria guide diagnosis (TEE is the gold standard for vegetations).
    ✅ Blood cultures BEFORE antibiotics!
    ✅ Long-term IV antibiotics are required (4–6 weeks).
    ✅ Surgery indicated for severe valve damage, large vegetations, or abscesses.

    Total
    0
    Shares
    Share 0
    Tweet 0
    Pin it 0
    Share 0
    Dr Ben
    • Website

    Related Posts

    Myocardial Infarction (MI): Pathophysiology, Diagnosis, and Management

    March 18, 2025
    Read More

    Electrocardiogram (ECG) Interpretation: A Detailed Guide for Medical Professionals

    March 17, 2025
    Read More

    Comparison of Common Arrhythmias: AF, Atrial Flutter, SVT, VT, VF, and Torsades de Pointes

    March 17, 2025
    Read More

    Leave A Reply Cancel Reply

    Recent Posts
    • Erythema Multiforme: Recognition, Triggers, and Management
    • Dermatophyte Infections: Tinea Capitis, Cruris, and Corporis – Recognition and Management
    • Impetigo: Recognition, Causes, and Management
    • Folliculitis: Causes, Clinical Features, and Management
    • Acne Vulgaris vs Rosacea: Key Features, Differences, and Management
    Facebook Twitter Instagram Pinterest
    • Home
    • About
    • Contact
    • Disclaimer
    • Privacy Policy
    • Terms and Conditions
    © 2025 ThemeSphere. Designed by ThemeSphere.

    Type above and press Enter to search. Press Esc to cancel.